Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H15BrN2 |
| Molecular Weight | 303.197 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC\C=C(\C1=CC=C(Br)C=C1)C2=CN=CC=C2
InChI
InChIKey=AZFZKANGXPSDEA-NVNXTCNLSA-N
InChI=1S/C15H15BrN2/c1-17-10-8-15(13-3-2-9-18-11-13)12-4-6-14(16)7-5-12/h2-9,11,17H,10H2,1H3/b15-8-
| Molecular Formula | C15H15BrN2 |
| Molecular Weight | 303.197 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Nomelidine (norzimelidine), the active N-demethylated metabolite of zimelidine, is a potent and specific inhibitor of [14C]5-HT uptake in synaptosome rich homogenates of rat hypothalamus. Nomelidine inhibits the uptake of 5-HT more potently than the parent compound. Zimelidine (ZIM) and its main active metabolite norzimelidine (NZIM) have been shown to preferentially inhibit 5-hydroxytryptamine (5-HT) neuronal uptake both in vitro and in vivo while having much less effect on noradrenaline (NA) uptake.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Norzimelidine, a metabolite of a highly selective 5-hydroxytryptamine uptake inhibitor, can inhibit the uptake of noradrenaline in-vivo. | 1984-12 |
|
| The antidepressant agents desipramine, fluoxetine, fluvoxamine and norzimelidine inhibit uptake of [3H]noradrenaline and [3H]5-hydroxytryptamine in slices of human and rat cortical brain tissue. | 1983-09-19 |
|
| Pharmacokinetics of zimelidine in humans--plasma levels and urinary excretion of zimelidine and norzimelidine after intravenous and oral administration of zimelidine. | 1981 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6151986
Mice: norzimelidine (20-40 mg kg-1)
moderately antagonized the hypothermia induced by
reserpine; norzimelidine (10-40 mg kg-1) antagonized, in a dose-dependent manner, the hypothermia
induced by 16 mg kg-1 of apomorphine.
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1786378
Nomelidine (norzimelidine) (5 X 10(-5) M) was more potent inhibitor of the 3H-EN uptake than that of 3H-NE into rat brain crude synaptosomes.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:25:22 GMT 2025
by
admin
on
Mon Mar 31 18:25:22 GMT 2025
|
| Record UNII |
FVL27C1DMG
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C265
Created by
admin on Mon Mar 31 18:25:22 GMT 2025 , Edited by admin on Mon Mar 31 18:25:22 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
FVL27C1DMG
Created by
admin on Mon Mar 31 18:25:22 GMT 2025 , Edited by admin on Mon Mar 31 18:25:22 GMT 2025
|
PRIMARY | |||
|
SUB09346MIG
Created by
admin on Mon Mar 31 18:25:22 GMT 2025 , Edited by admin on Mon Mar 31 18:25:22 GMT 2025
|
PRIMARY | |||
|
DTXSID501024244
Created by
admin on Mon Mar 31 18:25:22 GMT 2025 , Edited by admin on Mon Mar 31 18:25:22 GMT 2025
|
PRIMARY | |||
|
5378630
Created by
admin on Mon Mar 31 18:25:22 GMT 2025 , Edited by admin on Mon Mar 31 18:25:22 GMT 2025
|
PRIMARY | |||
|
C75173
Created by
admin on Mon Mar 31 18:25:22 GMT 2025 , Edited by admin on Mon Mar 31 18:25:22 GMT 2025
|
PRIMARY | |||
|
CHEMBL287064
Created by
admin on Mon Mar 31 18:25:22 GMT 2025 , Edited by admin on Mon Mar 31 18:25:22 GMT 2025
|
PRIMARY | |||
|
60324-59-6
Created by
admin on Mon Mar 31 18:25:22 GMT 2025 , Edited by admin on Mon Mar 31 18:25:22 GMT 2025
|
PRIMARY | |||
|
100000083587
Created by
admin on Mon Mar 31 18:25:22 GMT 2025 , Edited by admin on Mon Mar 31 18:25:22 GMT 2025
|
PRIMARY | |||
|
4545
Created by
admin on Mon Mar 31 18:25:22 GMT 2025 , Edited by admin on Mon Mar 31 18:25:22 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |